Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Total Non-Current Liabilities (2018 - 2025)

Ocular Therapeutix has reported Total Non-Current Liabilities over the past 10 years, most recently at $152.9 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $152.9 million for Q4 2025, up 18.18% from a year ago — trailing twelve months through Dec 2025 was $152.9 million (up 18.18% YoY), and the annual figure for FY2025 was $152.9 million, up 18.18%.
  • Total Non-Current Liabilities for Q4 2025 was $152.9 million at Ocular Therapeutix, roughly flat from $152.5 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for OCUL hit a ceiling of $160.8 million in Q4 2023 and a floor of $86.3 million in Q1 2021.
  • Median Total Non-Current Liabilities over the past 5 years was $118.0 million (2023), compared with a mean of $119.7 million.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 53.27% in 2023 and later dropped 19.57% in 2024.
  • Ocular Therapeutix's Total Non-Current Liabilities stood at $96.7 million in 2021, then increased by 17.8% to $113.9 million in 2022, then surged by 41.18% to $160.8 million in 2023, then fell by 19.57% to $129.3 million in 2024, then increased by 18.18% to $152.9 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $152.9 million (Q4 2025), $152.5 million (Q3 2025), and $131.4 million (Q2 2025) per Business Quant data.